Skip to content

Development of an MRI scanning protocol for functional imaging of esophageal cancer.

Development of an MRI scanning protocol for functional imaging of esophageal cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29032
Enrollment
30
Registered
2013-02-04
Start date
2013-02-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

None (patients undergo an MRI scan with contrast agent).

Sponsors

UMC Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with pathologically proven esophageal cancer referred to the department of Radiotherapy for radiotherapy; 2. >18 years; 3. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Glomerular Filtration Rate (GFR) of <45 mL/min/1.73m2, unless the patient has risk factors for contrast nefropathy according to the UMCU protocol ‘Preventie contrastreactie en contrast nefropathie, Versie 2 februari 2012’. In patients with risk factors a GFR of 60 mL/min/1.73m2 will be required; 2. Known Gadovist allergy; 3. Patients who meet exclusion criteria for MRI following the protocol of the radiology department of the UMC Utrecht.

Design outcomes

Primary

MeasureTime frame
Quality of the MRI images as defined by robustness (i.e. that the protocol can successfully be applied in various patients) and geometrical accuracy. Those parameters are derived using image analysis. MR images are obtained before, during and/or after chemoradiotherapy.

Contacts

Public ContactA.L.H.M.W. Lier, van

Heidelberglaan 100

a.l.h.m.w.vanlier@umcutrecht.nl+31 (0)88 7558800

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)